Pharmaceutical Merchants Want to Perfect Investment

From the aspects of resource optimization and regional advantages, pharmaceutical investment merchants have accumulated more or less their own advantageous resources through many years of operation. These resources ensure that products can smoothly enter the market. Especially in some regional markets, the huge advantage of pharmaceutical investment agency companies is that they cannot be established in the short term. These huge advantages are all necessary for the production companies. This is also the precondition and basis for the cooperation of manufacturers. However, these alone are still far from enough. Pharmaceutical investment promotion companies, especially regional SMEs, need to do a good job in three areas if they want to recruit good business.

In the case of pharmaceutical investment promotion, it is necessary to obtain better investment results to develop itself, to have the right to negotiate with upstream manufacturers to obtain as many good products as possible, and also to work hard on its own core competitiveness. Pharmaceutical companies use products as the prerequisite for marketing, and pharmaceutical investment companies are even more so. In the business process of pharmaceutical investment enterprises, the creation of star products and star markets for pharmaceutical investment enterprises is the core of whether the company can have breakthroughs in development.

While doing good management of old customers, another aspect of the development of pharmaceutical investment agency companies is the development of new customers. It can be said that which company has stronger new customer development capabilities, then the company's sales and profits will be more secure. In the past few years, advertisements for pharmaceutical companies were initially advertised as kings. As long as media propaganda is done well, there will be a large number of pharmaceutical investment agents actively taking the initiative to seek out product agents. However, nowadays, with the unprecedented prosperity of the media and the increasingly rational nature of pharmaceutical agents, if media information is not published accurately, the effect is not good, and resources are wasted. Therefore, it is necessary to combine active telephone investment and information release.

On the one hand, the media publishes information on the road of precision, and on the other hand, it can use the most active information on investment promotion agents to attract investment, which can maximize the effect of investment promotion. In the communication and exchange with new customers, pharmaceutical investment companies must speak with integrity. In terms of cooperation, we must focus on efficiency and ensure a win-win situation. We must not do a one-hit sale. In the current environment of experience, there is no room for survivors to abduct and swindle. Cooperation partners must not only safeguard their own interests, but also make the other party profitable.

For pharmaceutical investment promotion companies, after years of accumulation and precipitation, each pharmaceutical investment agency has many agents and client resources. Many of them are customers who have cooperated with enterprises for many years and have high loyalty. This is the basis for the survival of investment enterprises. The cost of developing a new customer is ten times that of maintaining an old customer. The fact that more than 95% of the sales of pharmaceutical companies are provided by old customers proves that how to let old customers increase sales is an important task for the company. Nowadays, many companies have established large customer management departments and special people are responsible for the company's major customers' sales and services. The core of VIP customer service is to ensure the company's sales stability, and at the same time hopes to increase the quantity and quality of cooperation between the two parties through specialized services.

The establishment of investment promotion brands by pharmaceutical investment promotion companies should focus on three aspects: 1. To issue timely brand promotion in the authoritative media of the industry and to report and publicize by these authoritative media. It is believed that with the reports of these sections, the investment brand is bound to establish itself. It also has a different effect on investment enterprises. 2, is focused on the pharmaceutical industry's Internet publicity, the current rapid development of the Internet, in the major pharmaceutical websites for publicity, this is to create a channel brand image of the most efficient and efficient way. 3, focus on long-term pragmatic drug investment operation, establish an effective agency brand reputation. Under the premise of non-standard operation of the overall market, the power of word-of-mouth publicity is huge, and the effect of word-of-mouth publicity cannot be measured.

If pharmaceutical investment enterprises want to develop for a long time, they must position themselves in the market products they are doing. They can't behave as if they are eyebrows and beards. As long as they are drugs, they are doing business. In fact, this blind practice is extremely wrong. This is often not the case. Focus on the positioning of its own product market is not clear, eventually leading to complex product varieties and lack of competitiveness. At present, the investment products selected by the various investment enterprises are nothing more than these categories: real new effective drugs, real new effective drugs, improved product formulations, replacement packaging, re-listed drugs and general drugs after the conversion of specifications, that is, those There is no need to highlight any local drug investment.